Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-26

Clinical Trial Update: Varenicline and Alcohol in Inpatient Addictions Program (IAP) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating varenicline for comorbid alcoholism and nicotine dependence was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: Mayo Clinic | Conditions: Alcoholism, Nicotine Dependence | Phase 3 | Status: TERMINATED | Results posted: 2013-09-26